The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).

The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).

Détails bibliographiques
Auteurs principaux:	Kaltsas, G, Papadogias, D, Grossman, AB
Format:	Journal article
Langue:	English
Publié:	2004

Documents similaires

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
par: Chrisoulidou, A, et autres
Publié: (2007)

The clinical genetics of phaeochromocytoma and paraganglioma
par: P. T. Kavinga Gunawardane, et autres

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
par: Bomanji, J, et autres
Publié: (1993)

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
par: Bouloux, P, et autres
Publié: (1986)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
par: Mukherjee, J, et autres
Publié: (2001)

Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management
par: Foo, S.H., et autres
Publié: (2010)

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
par: Srirangalingam, U, et autres
Publié: (2008)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
par: Kaltsas, G, et autres
Publié: (2005)

Phaeochromocytoma and Paraganglioma Excision Involving the Great Vessels
par: U. Srirangalingam, et autres
Publié: (2017-01-01)

Using parenclitic networks on phaeochromocytoma and paraganglioma tumours provides novel insights on global DNA methylation
par: Dimitria Brempou, et autres
Publié: (2024-12-01)

Personalized diagnostics of chromaffin tumors (pheochromocytoma, paraganglioma) in oncoendocrinology
par: Pavel O. Rumyantsev, et autres
Publié: (2018-07-01)

Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma
par: Sofia Maria Lider Burciulescu, et autres
Publié: (2023-02-01)

A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma
par: Christopher S. Boot
Publié: (2023-09-01)

Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
par: Srirangalingam, U, et autres
Publié: (2009)

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
par: Kaltsas, G, et autres
Publié: (2004)

Phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension.
par: Frankton, S, et autres
Publié: (2009)

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
par: Astuti, D, et autres
Publié: (2003)

Predictors of outcome in phaeochromocytomas and paragangliomas [version 1; referees: 3 approved]
par: Marlo Nicolas, et autres
Publié: (2017-12-01)

A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
par: Prodromos Chatzikyriakou, et autres
Publié: (2023-12-01)

Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
par: Druce, MR, et autres
Publié: (2009)

The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
par: Samsudin, Intan Nureslyna, et autres
Publié: (2018)

Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis
par: Andrea Luchetti, et autres
Publié: (2015-01-01)

Genetic testing and immunohistochemistry for SDHB in phaeochromocytoma-paraganglioma syndromes: the South Australian experience
par: Poplawski NK, et autres
Publié: (2012-04-01)

The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.
par: Sheaves, R, et autres
Publié: (1995)

Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.
par: Nölting, S, et autres
Publié: (2012)

The use of temozolomide in paediatric metastatic phaeochromocytoma/paraganglioma: A case report and literature review
par: Calum Urquhart, et autres
Publié: (2022-11-01)

Unilateral Sporadic Carotid Paraganglioma
par: Sushil G. Kachewar, et autres
Publié: (2011-12-01)

Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.
par: Dahia, P, et autres
Publié: (1997)

Malignant pituitary tumours.
par: Kaltsas, G, et autres
Publié: (1998)

Rare presentation of collapse and cardiomyopathy in phaeochromocytoma
par: Rajiv Singh, et autres
Publié: (2021-05-01)

Phaeochromocytoma Crisis: Two Cases of Undiagnosed Phaeochromocytoma Presenting after Elective Nonrelated Surgical Procedures
par: P. C. Johnston, et autres
Publié: (2013-01-01)

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
par: Wong Nora, et autres
Publié: (2006-01-01)

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
par: Nastos, K, et autres
Publié: (2017)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
par: Lawrence, J, et autres
Publié: (2004)

Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
par: Kaltsas, G, et autres
Publié: (2002)

Intracerebral haemorrhage: A rare presentation of phaeochromocytoma
par: Swati Chhikara, et autres
Publié: (2021-01-01)

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
par: Kaltsas, G, et autres
Publié: (2003)

A Rare Case: Sporadic Bladder Paraganglioma
par: Hakan Ercil, et autres
Publié: (2013-08-01)

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
par: David J. Pinato, et autres
Publié: (2017-11-01)

MIBG scans for phaeochromocytoma: time to abandon the technique?
par: Grossman, A, et autres
Publié: (2009)